Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Swedish Orphan Biovitrum SOBI.ST | Pharmaceuticals: Major | $16.1B | +6% | +6% | +15% | 30% | 24.1× |
| Getinge GETI-B.ST | Medical Specialties | $7.45B | +7% | +40% | -4% | 14% | 21.1× |
| Camurus CAMX.ST | Pharmaceuticals: Major | $4.36B | +10% | +36% | +3% | 38% | 45.1× |
| Medicover MCOV-B.ST | Medical/Nursing Services | $3.87B | -3% | +21% | +3% | 7% | 36.1× |
| Asker Healthcare ASKER.ST | Medical Distributors | $2.69B | +2% | -14% | +12% | 7% | 24.8× |
| BioArctic BIOA-B.ST | Pharmaceuticals: Major | $2.66B | +1% | -9% | -46% | 22% | 52.9× |
| Elekta EKTA-B.ST | Medical Specialties | $2.35B | +12% | 0% | -7% | 6% | 15.3× |
| Vimian VIMIAN.ST | Biotechnology | $2.26B | +14% | +51% | +8% | 19% | 38.4× |
| AddLife ALIF-B.ST | Medical/Nursing Services | $2.13B | -4% | +15% | +2% | 8% | 39.0× |
| Bonesupport BONEX.ST | Medical Specialties | $2.06B | +25% | +21% | +25% | 25% | 61.5× |
| Attendo ATT.ST | Services to the Health Industry | $1.87B | +13% | +15% | 0% | 10% | 16.9× |
| Ambea AMBEA.ST | Medical/Nursing Services | $1.59B | +5% | +28% | +11% | 9% | 15.2× |
| Vitrolife VITR.ST | Medical Specialties | $1.57B | +20% | +13% | -2% | 19% | 27.0× |
| BioGaia BIOG-B.ST | Pharmaceuticals: Other | $1.25B | +1% | -4% | +13% | 28% | 31.0× |
| Arjo ARJO-B.ST | Medical Distributors | $974M | +30% | +42% | 0% | 8% | 21.1× |
| MedCap MCAP.ST | Medical Specialties | $811M | +1% | -4% | +17% | 15% | 25.8× |
| Xvivo Perfusion XVIVO.ST | Medical Specialties | $611M | -14% | -32% | +18% | 12% | 53.1× |
| Egetis Therapeutics EGTX.ST | Pharmaceuticals: Major | $509M | +21% | +76% | +27% | -645% | 15.1× |
| Hansa Biopharma HNSA.ST | Pharmaceuticals: Major | $479M | +25% | +39% | +69% | -190% | n/a |
| CellaVision CEVI.ST | Medical Specialties | $477M | +24% | +64% | +2% | 23% | 32.6× |
| Swedencare SECARE.ST | Pharmaceuticals: Major | $321M | -13% | -24% | +3% | 7% | 24.9× |